LLY
Eli Lilly and Company
1,152.90$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 25.1% | 25.2% | 26.9% | 22.3% | 21.8% | 21.2% | 22.3% | 25.8% | 23.2% | 20.8% | 18.7% | 16.2% | |
| 74.9% | 74.8% | 73.1% | 77.7% | 78.2% | 78.8% | 77.7% | 74.2% | 76.8% | 79.2% | 81.3% | 83.8% | |
| 24.1% | 24.0% | 25.0% | 25.5% | 23.5% | 25.1% | 24.4% | 24.5% | 25.2% | 27.3% | 24.4% | 20.5% | |
| 33.8% | 32.7% | 29.8% | 30.9% | 26.7% | 26.9% | 23.9% | 21.7% | 21.3% | 20.3% | 18.1% | 17.0% | |
| 57.9% | 56.8% | 54.9% | 56.5% | 50.2% | 52.0% | 48.3% | 46.2% | 46.5% | 47.6% | 42.5% | 38.2% | |
| 17.0% | 18.0% | 18.2% | 21.3% | 28.0% | 26.9% | 29.4% | 28.0% | 30.3% | 31.6% | 38.9% | 45.6% | |
| 0.8% | 0.8% | 0.9% | 1.1% | 1.1% | 1.8% | 1.5% | 1.2% | 1.2% | 1.4% | 1.7% | 1.2% | |
| 15.3% | 14.0% | 15.9% | 11.5% | 17.1% | 23.6% | 29.5% | 21.7% | 23.8% | 19.2% | 28.2% | 39.5% | |
| 3.1% | 1.9% | 3.0% | 12.0% | 2.5% | 2.8% | 4.2% | 2.0% | 2.0% | 3.9% | 4.6% | 7.8% | |
| 12.2% | 12.1% | 12.9% | -1.0% | 15.0% | 37.3% | 25.2% | 19.7% | 21.9% | 15.4% | 23.5% | 31.7% | |
| 23.1% | 21.9% | 23.8% | 20.5% | 25.7% | 30.9% | 36.3% | 28.4% | 30.3% | 25.1% | 33.8% | 42.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.